Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Platinum Retreated in Patients with Platinum Sensitive mTNBC
NCT02607215Phase 2Unknown
- Sponsor
- Fudan University
- Start
- Nov 2015
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cisplatin in triple-negative breast cancer (TNBC), sponsored by Fudan University. Status: unknown.
02
Drugs
cisplatin
03
Conditions
triple-negative breast cancer (TNBC)
Beyond the preview
Go deeper on NCT02607215.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02607215.